Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Gains from Investment Securities (2022 - 2025)

Bioregenx has reported Gains from Investment Securities over the past 4 years, most recently at $47.3 million for Q2 2025.

  • For Q2 2025, Gains from Investment Securities changed N/A year-over-year to $47.3 million; the TTM value through Dec 2025 reached $19351.0, down 91.66%, while the annual FY2025 figure was $43.1 million, 8.85% down from the prior year.
  • Gains from Investment Securities for Q2 2025 was $47.3 million at Bioregenx, up from $7.9 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $47.3 million in Q2 2025 and troughed at -$79400.0 in Q2 2022.
  • A 4-year average of $5.5 million and a median of $20200.0 in 2022 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: crashed 349.02% in 2023 and later soared 15674.8% in 2024.
  • Year by year, Gains from Investment Securities stood at $39000.0 in 2022, then skyrocketed by 575.31% to $263371.0 in 2023, then soared by 2904.13% to $7.9 million in 2024, then surged by 497.92% to $47.3 million in 2025.
  • Business Quant data shows Gains from Investment Securities for BRGX at $47.3 million in Q2 2025, $7.9 million in Q3 2024, and $19351.0 in Q1 2024.